Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where T. Cai is active.

Publication


Featured researches published by T. Cai.


World Journal of Urology | 2016

Antimicrobial resistance in urosepsis: outcomes from the multinational, multicenter global prevalence of infections in urology (GPIU) study 2003–2013

Zafer Tandogdu; R. Bartoletti; T. Cai; Mete Cek; Magnus Grabe; Ekaterina Kulchavenya; Béla Köves; Vandana Menon; Kurt G. Naber; Tamara Perepanova; Peter Tenke; Björn Wullt; Truls E. Bjerklund Johansen; Florian Wagenlehner

AbstractObjectivenPrimary objective was to identify the (1) relationship of clinical severity of urosepsis with the pathogen spectrum and resistance and (2) appropriateness of using the pathogen spectrum and resistance rates of health-care-associated urinary tract infections (HAUTI) as representative of urosepsis. The secondary objective was to provide an overview of the pathogens and their resistance profile in patients with urosepsis.Population and MethodsnA point prevalence study carried out in 70 countries (2003–2013). Population studied included; 408 individuals with microbiologically proven urosepsis, 1606 individuals with microbiological proof of HAUTI and 27,542 individuals hospitalised in urology wards. Main outcomes are pathogens and resistance identified in HAUTIs and urosepsis including its clinical severity. A statistical model that included demographic factors (study year, geographical location, hospital setting) was used for analysis.ResultsAmongst urology practices, the prevalence of microbiologically proven HAUTI and urosepsis was 5.8 and 1.5xa0%, respectively. Frequent pathogens in urosepsis were E. coli (43xa0%), Enterococcus spp. (11xa0%), P. aeruginosa (10xa0%) and Klebsiella spp. (10xa0%). Resistance to commonly prescribed antibiotics was high and rates ranged from 8xa0% (imipenem) to 62xa0% (aminopenicillin/β lactamase inhibitors); 45xa0% of Enterobacteriaceae and 21xa0% of P. aeruginosa were multidrug-resistant. Resistance rates in urosepsis were higher than in other clinical diagnosis of HAUTI (Likelihood ratio <0.05).ConclusionsIt is not appropriate to use the pathogen spectrum and resistance rates of other HAUTIs as representative of urosepsis to decide on empirical treatment of urosepsis. Resistance rates in urosepsis are high, and precautions should be made to avoid further increase.


European urology focus | 2017

Non-molecular Methods to Detect Bacteriuria Prior to Urological Interventions: A Diagnostic Accuracy Systematic Review

Gernot Bonkat; Olivier Braissant; T. Cai; Béla Köves; Truls E. Bjerklund Johansen; Robert Pickard; Rajan Veeratterapillay

Urine culture still has to be considered as the gold standard to rule out bacteriuria and should, therefore, be obtained prior to invasive endoscopic or open urological procedures to minimize the risk of severe infectious complications.


European Urology Supplements | 2015

136 Adherence to European Association of Urology guidelines on prophylactic antibiotics: An important step in antimicrobial stewardship

T. Cai; Paolo Verze; Anna Brugnolli; Daniele Tiscione; Gianni Malossini; Lorenzo Giuseppe Luciani; C. Echher; F. Wagenlehner; Vincenzo Mirone; T.E. Bjerklund Johansen; Robert Pickard; R. Bartoletti


European Urology Supplements | 2018

Epidemiological features of resistance patterns among uropathogens: Focus on fosfomycin trometamol

Paolo Lanzafame; T. Cai; P. Caciagli; Alessandro Palmieri; Paolo Verze; Davide Arcaniolo; Vincenzo Mirone; Gianni Malossini


European Urology Supplements | 2018

Characterization of the novaginal microflora after surgical gender reassignment in HIV, HBV and HCV Seronegative transsexual women

Michele Rizzo; G. Campisciano; F. Migliozzi; Giovanni Liguori; Stefano Bucci; A. Cocci; T. Cai; Carlo Trombetta; M. Comar


European Urology Supplements | 2018

L-Metionina associated with ibiscus sabdariffa and boswellia serrata (ACIDIF PLUS®) extracts in patients affected by recurrent uncomplicated urinary tract infections: Is it a feasible alternative to antibiotic treatment?

T. Cai; Daniele Tiscione; A. Cocci; Paolo Verze; Alessandro Palmieri; Vincenzo Mirone; Gianni Malossini


European Urology Supplements | 2018

L-metionina associated with Hibiscus sabdariffa and Boswellia serrata (ACIDIF PLUS®) extracts is able to relief symptoms and improve quality of life in patients affected by recurrent uncomplicated urinary tract infections

T. Cai; Daniele Tiscione; Paolo Lanzafame; Lorenzo Giuseppe Luciani; R. Bartoletti; Gianni Malossini


European Urology Supplements | 2018

Too many negative Meares-Stamey tests: What is the reason?

T. Cai; Sandra Mazzoli; Paolo Lanzafame; P. Caciagli; Daniele Tiscione; Gianni Malossini; Paolo Verze; Alessandro Palmieri; R. Bartoletti; Vincenzo Mirone


European Urology Supplements | 2018

Selective arterial clamping with near-infrared fluorescence versus standard clamping during robot-assisted partial nephrectomy: Operative and early functional results based on renal scan

Daniele Mattevi; G.L. Luciani; S. Chiodini; M. Puglisi; V. Vattovani; T. Cai; Gianni Malossini


European Urology Supplements | 2018

Combined use of 3D reconstruction plus near-infrared fluorescence during robot-assisted partial nephrectomy

Lorenzo Giuseppe Luciani; Daniele Mattevi; S. Chiodini; M. Puglisi; V. Vattovani; T. Cai; Gianni Malossini

Collaboration


Dive into the T. Cai's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Paolo Verze

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar

Vincenzo Mirone

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

A. Cocci

University of Florence

View shared research outputs
Top Co-Authors

Avatar

Alessandro Palmieri

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge